Fingerprint
Dive into the research topics of 'Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?
Ashish Saharia, Lucy M Potter, Flavio Baio, Ahmed Elaileh, Constance Mobley, Rafik M Ghobrial, Maen Abdelrahim, Kirk Heyne
- Houston Methodist Sugar Land Hospital
- Academic Institute
- Department of Surgery
- Sherrie and Alan Conover Center for Liver Disease & Transplantation
- J.C. Walter Jr. Transplant Center
- Houston Methodist
- Weill Cornell Medical College
- Houston Methodist Hospital
- Research Institute
- Immunobiology & Transplant Science Center
- Dr. Mary and Ron Neal Cancer Center
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations